2-Benzylbenzyl methanesulfonate | 1026077-03-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Benzylbenzyl methanesulfonate
• 英文别名: (2-Benzylphenyl)methyl methanesulfonate
• CAS: 1026077-03-1
• 化学式: C₁₅H₁₆O₃S
• 分子量: 276.356
• InChiKey: NBEGCOFCMAZRDL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  51.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-Benzylbenzyl methanesulfonate 在 phosphorus pentoxide 、 sodium hydride 、 sodium cyanoborohydride 作用下， 以 溶剂黄146 、 甲苯 为溶剂， 反应 4.33h， 生成 5-Benzyl-1,4-dihydro-2H-isoquinoline-3,3-dicarboxylic acid diethyl ester
  参考文献：
  名称：

  A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site

  摘要：

  The availability of peptide and non-peptide Ang II receptor antagonists has permitted the study of Ang II receptor heterogeneity. It is now widely recognized that there are at least two distinct Ang II receptor subtypes. AT(1) receptors are selective in their recognition of agents such as losartan, DuP 532, L-158,809, SK&F108566, and similar non-peptides. To date, all of the well-known actions of Ang II in mammals are blocked by the AT(1) selective antagonists such as losartan and are thus designated as being mediated by the AT(1) receptor. Although there have been reports of functional activity mediated through AT(2) sites, the pharmacological role for the AT(2) receptor has not yet been elucidated. Herein, we report the chemistry and SAR on a novel series of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids which have selective affinity for AT(2) receptors. The most potent of which (19) has an IC50 Of 30 nM for the AT(2) receptor in the rat adrenal radioligand binding assay.

  DOI：

  10.1021/jm00077a001
• 作为产物：
  描述：

  2-苄基苯甲醇 、 甲基磺酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 2-Benzylbenzyl methanesulfonate
  参考文献：
  名称：

  New pyrazole derivatives having CRTh2 antagonistic behaviour

  摘要：

  这项发明涉及一种化合物的公式(I)，以及制备这种化合物的方法，以及它们在治疗病理状况或疾病中的应用，这些病理状况或疾病容易通过CRTh2拮抗活性得到改善。

  公开号：

  EP2457900A1

文献信息

• [EN] NEW PYRAZOLE DERIVATIVES HAVING CRTH2 ANTAGONISTIC BEHAVIOUR<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRAZOLE POSSÉDANT UN COMPORTEMENT ANTAGONISTE DE CRTH2
  申请人：ALMIRALL SA

  公开号：WO2012069175A1

  公开（公告）日：2012-05-31

  The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

  本发明涉及一种式(I)的化合物，以及制备这种化合物的方法，以及它们在治疗病理状况或疾病中的应用，这些病理状况或疾病容易通过CRTh2拮抗活性得到改善。
• New pyrazole derivatives having CRTh2 antagonistic behaviour
  申请人：Almirall, S.A.

  公开号：EP2457900A1

  公开（公告）日：2012-05-30

  The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

  这项发明涉及一种化合物的公式(I)，以及制备这种化合物的方法，以及它们在治疗病理状况或疾病中的应用，这些病理状况或疾病容易通过CRTh2拮抗活性得到改善。
• A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site
  作者：Mary K. VanAtten、Carol L. Ensinger、Andrew T. Chiu、Dale E. McCall、Tam T. Nguyen、Ruth R. Wexler、Pieter B. M. W. M. Timmermans

  DOI：10.1021/jm00077a001

  日期：1993.12

  The availability of peptide and non-peptide Ang II receptor antagonists has permitted the study of Ang II receptor heterogeneity. It is now widely recognized that there are at least two distinct Ang II receptor subtypes. AT(1) receptors are selective in their recognition of agents such as losartan, DuP 532, L-158,809, SK&F108566, and similar non-peptides. To date, all of the well-known actions of Ang II in mammals are blocked by the AT(1) selective antagonists such as losartan and are thus designated as being mediated by the AT(1) receptor. Although there have been reports of functional activity mediated through AT(2) sites, the pharmacological role for the AT(2) receptor has not yet been elucidated. Herein, we report the chemistry and SAR on a novel series of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids which have selective affinity for AT(2) receptors. The most potent of which (19) has an IC50 Of 30 nM for the AT(2) receptor in the rat adrenal radioligand binding assay.